EYED PHARMA
0508.599.605 · rovalta.com · 24/09/2026
ACTIVE
EYED PHARMA
Financial year 2024 · closed on 31/12/2024
Net result
-6,9 M €
-15.0% YoY
Revenue
11,8 M €
Equity
22,8 M €
-17.2% YoY
Workforce
33,5 ETP
-1.5% YoY
Overview
What does EYED PHARMA do?
EYED PHARMA is a Public limited company incorporated in 2012. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Seraing. It employs on average 33,5 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0508.599.605
Incorporation
20/12/2012
Legal form
Public limited company
Registered office
Rue Louis Plescia 9
4102 Seraing · WallonieSee on map
4102 Seraing · WallonieSee on map
Contributed capital
24 847 913,00 €
Latest accounts
31/12/2024
Average workforce
33,5 ETP
Activities (NACE)
Joint committees (1)
- 207
Signals
Solid equityGood liquidityHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 10 financial years
| 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||
| Revenue | 11,8 M € | – | – | – | – | – | – | – | – | – | |||||||||
| EBITDA | -3,9 M € | -7.4% | -3,6 M € | +20.3% | -4,6 M € | -45.7% | -3,1 M € | -87.0% | -1,7 M € | -246% | -483,6 k € | -30.4% | -370,9 k € | -2947% | 13 k € | +108% | -163,1 k € | -411% | -31,9 k € |
| Operating result | -8,3 M € | -7.1% | -7,8 M € | -5.3% | -7,4 M € | -43.5% | -5,1 M € | -125% | -2,3 M € | -170% | -842,6 k € | +5.0% | -887,1 k € | -574% | -131,5 k € | +28.9% | -185,1 k € | -265% | -50,7 k € |
| Net result | -6,9 M € | -15.0% | -6 M € | +4.4% | -6,3 M € | -34.7% | -4,7 M € | -164% | -1,8 M € | -152% | -703 k € | -33.7% | -525,7 k € | -148% | -212,4 k € | -14.9% | -184,9 k € | -265% | -50,7 k € |
| Balance sheet | |||||||||||||||||||
| Equity | 22,8 M € | -17.2% | 27,5 M € | +68.9% | 16,3 M € | -19.5% | 20,2 M € | +653% | 2,7 M € | +74.5% | 1,5 M € | -17.3% | 1,9 M € | +240% | 547,3 k € | +1637% | -35,6 k € | -124% | 149,3 k € |
| Total assets | 42,3 M € | +11.8% | 37,9 M € | +39.7% | 27,1 M € | -17.2% | 32,7 M € | +346% | 7,3 M € | +118% | 3,4 M € | +24.1% | 2,7 M € | +116% | 1,3 M € | +200% | 418,8 k € | +99.4% | 210,1 k € |
| Cash | 1,2 M € | +17.5% | 1 M € | -70.2% | 3,5 M € | -74.3% | 13,5 M € | +2242% | 576,5 k € | +18.5% | 486,5 k € | -71.5% | 1,7 M € | +778% | 194,3 k € | -8.8% | 212,9 k € | +38.0% | 154,2 k € |
| Debts | 19,5 M € | +89.2% | 10,3 M € | -4.1% | 10,8 M € | -13.5% | 12,5 M € | +168% | 4,6 M € | +155% | 1,8 M € | +115% | 849,2 k € | +19.6% | 709,9 k € | +56.2% | 454,5 k € | +648% | 60,8 k € |
| Other | |||||||||||||||||||
| Workforce | 33,5 ETP | -1.5% | 34,0 ETP | -15.0% | 40,0 ETP | +25.0% | 32,0 ETP | – | – | – | 0,7 ETP | +40.0% | 0,5 ETP | +400% | 0,1 ETP | ||||
Estimate
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2024 · 9 active · 42 ended
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
BESINS HEALTHCARE PHARMTECH● Active | 0736.939.187 |
Financials
Annual accounts
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/07/2025 | 17/07/2024 | 28/06/2023 | 23/08/2022 | 31/08/2021 | 31/08/2020 |
| General meeting | 03/07/2025 | 28/06/2024 | 13/06/2023 | 14/06/2022 | 20/08/2021 | 06/08/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
12 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 03/07/2025 | 28/07/2025 | French | |
| Abridged model | 31/12/2023 | 28/06/2024 | 17/07/2024 | French | |
| Abridged model | 31/12/2022 | 13/06/2023 | 28/06/2023 | French | |
| Abridged model | 31/12/2021 | 14/06/2022 | 23/08/2022 | French | |
| Abridged model | 31/12/2020 | 20/08/2021 | 31/08/2021 | French | |
| Abridged model | 31/12/2019 | 06/08/2020 | 31/08/2020 | French | |
| Micro model | 31/12/2018 | 28/06/2019 | 23/07/2019 | French | |
| Micro model | 31/12/2017 | 12/06/2018 | 31/08/2018 | French | |
| Micro model | 31/12/2016 | 13/06/2017 | 29/09/2017 | French | |
| Abridged model | 31/12/2015 | 14/06/2016 | 02/08/2016 | French | |
| Abridged model | 31/12/2014 | 09/06/2015 | 31/08/2015 | French | |
| Abridged model | 31/12/2013 | 10/06/2014 | 25/08/2014 | French |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2024 · 9 active · 42 ended
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Capital / shares28/04/2026CAPITAL, ACTIONS
- Mandates18/11/2025DEMISSIONS, NOMINATIONS
- Mandates23/11/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates04/04/2023DEMISSIONS, NOMINATIONS
- Mandates24/01/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Registered office23/05/2022SIEGE SOCIAL
- Mandates27/12/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Capital / shares30/04/2021CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-6,9 M €↓
- 2023Annual accounts 2023-6 M €↑
- 2022Annual accounts 2022-6,3 M €↓
- 2021Annual accounts 2021-4,7 M €↓
- 2018Annual accounts 2018-1,8 M €↓
- 2017Annual accounts 2017-703 k €↓
- 2016Annual accounts 2016-525,7 k €↓
- 2015Annual accounts 2015-212,4 k €↓
- 2014Annual accounts 2014-184,9 k €↓
- 2013Annual accounts 2013-50,7 k €
- 20/12/2012IncorporationPublic limited company